Complete our Replication Project Readiness Assessment. Our online assessment will help you (1) assess whether you’re ready to apply for a Replication Project and (2) determine which TA track is most appropriate for you. This assessment was developed with support from Oscar Fleming from NIRN and is based on key activities from the Implementation Stages Framework.
Benefits for existing Innovation Station practices participating in a Replication Project include: Increase the visibility of your work and the reach of your program Receive national recognition and validation Develop the leadership skillsets of your staff regarding how to support someone in replicating your work and adapting it to their context Fulfill a criteria requirement to be…Continue reading What are the benefits of participating in a Replication Project if my practice is already in the Innovation Station database?
Benefits for organizations and agencies not already featured in the Innovation Station database participating in a Replication Project include: For community-based organizations, build relationships with your state’s Title V systems and systems in other states, and increase the visibility and reach of your work Learn from a peer state/territory/organization that has already implemented the program about experienced…Continue reading What are the benefits of participating in a Replication Project for organizations and agencies not already featured in the Innovation Station database?
AMCHP is continuing to strengthen and expand its focus on identifying and disseminating MCH practices that contribute to achieving equity, in particular racial equity. As a part of this newest iteration of the Replication Projects, we are looking for applicants that center on equitable implementation (including designing/planning, replicating/adapting, evaluating, scaling up, and communicating) of Innovation…Continue reading How is equity, particularly racial equity, embedded into the Replication Projects?
The 2021-2022 Replication Project will run from approximately May 2021-April 2022. AMCHP will provide two separate tracks of TA depending on an organization’s level of readiness to replicate an Innovation Station practice. One track focuses on capacity building and developing the infrastructure necessary to implement a practice in Innovation Station (the Capacity Building Track), and…Continue reading What is the structure and format of the Replication Projects?
For those who have participated or thought about participating in our Replication Projects, you’re not imagining things. Our application and TA opportunity really are different! To better meet the technical assistance needs of participating organizations, over the past year AMCHP worked with its Best Practices Committee as well as current and former Replication Project participants to reimagine…Continue reading Why does the format and structure of the projects different from past years?
You will see the following terms several times throughout our RFA: Technical Assistance Supporting individuals and organizations to increase their capacity to achieve an intended outcome. This may look like providing trainings, providing support to apply different tools, providing feedback/input on project activities, sharing relevant resources and materials. Core Components The key “ingredients” or activities…Continue reading How does AMCHP define commonly used terms in their RFA?
For the purpose of the Replication Project, AMCHP is only able to enter a contract with the entity who submitted the project application (grantee).
The grantee may use a fiscal agent to handle their administrative work. AMCHP will not have any relationship with the fiscal agent or third party. The grantee is responsible for signing the contract and will be the designated payee.
The grantee can begin planning pre-award activities before the contract is executed. However, AMCHP will not approve pre-award expenditures. Grantees may not submit invoices until the contract is signed. The first invoice received must fall after the date of the signed contract.